<h4>Background/objectives</h4>Small-cell prostate cancer (SCPC) is a rare, aggressive variant of prostate cancer with poor prognosis, arising "de novo" or through lineage plasticity from conventional adenocarcinoma under androgen receptor-targeted therapies. The gene discussed is AR; the disease is adenocarcinoma.